Which mutual funds hold Natco Pharma Limited?

18 mutual funds hold Natco Pharma Limited as of Sep 2026. The highest weight is 1.51% held by Tata India Pharma & Healthcare Fund-Direct Plan-Growth. Data from official AMFI monthly portfolio disclosures.

What sector is Natco Pharma Limited in?

Natco Pharma Limited is in the Pharmaceuticals & Biotechnology sector and is categorised as by SEBI.

What is the SEBI market cap category of Natco Pharma Limited?

As per SEBI and AMFI classification (Jan-Jun 2026), Natco Pharma Limited is a Small Cap stock ranked #380 with an average market cap of ₹17.39 K Cr.

Pharmaceuticals & Biotechnology

Natco Pharma Limited

ISIN: INE987B01026 · Data as of Sep 2026

Share: WhatsApp ✕ X

Search another stock:

Active Funds Holding

vs Last Month

+1 funds

Total Value

₹242.77 Cr

Avg Weight

0.9%

New Entries

Exits

Top Holder

Tata India Pharma & Healthcare Fund-Direct Plan-Growth 1.51%

ℹ️ Index funds and ETFs are excluded. Only actively managed funds reflect genuine fund manager decisions.

Small Cap Rank #380

₹10.54 K Cr

Avg Mkt Cap · Jan-Jun 2023 (3yr ago)

→

₹17.39 K Cr

Avg Mkt Cap · Jan-Jun 2026 (latest)

+65%

3yr change

SEBI · AMFI Market Cap List

📋 What Changed This Month Natco Pharma Limited is currently held by 18 active mutual funds with total exposure of ₹242.77 Cr. This month 3 funds entered and 2 funds exited. Tata India Pharma & Healthcare Fund-Direct Plan-Growth has the highest allocation at 1.51%. ↓ Scroll down for full fund list and monthly changes.

Trend

How Has Fund Coverage Changed — Last 5 Months?

Month	Funds	AUM (Cr)	AMCs	Status
Sep 2026 REFERENCE	18	₹243	48 / 49
Aug 2026	17	₹206	49 / 49	✅ Complete
Jul 2026	15	₹229	49 / 49	✅ Complete
Jun 2026	18	₹231	49 / 49	✅ Complete
May 2026	20	₹260	49 / 49	✅ Complete

📌 Portfolio changes below are based on Sep 2026 data — the most complete month with 48 AMCs we cover uploaded.

This Month

What Changed in the Portfolio — Sep 2026?

Note: Index funds and ETFs are excluded from this analysis. Their holdings change due to index rebalancing, not active fund manager decisions, and do not reflect genuine conviction buys or exits.

▲ New Entries (3)

Tata India Pharma & Healthcare Fund-Direct Plan-Growth 1.51%

ICICI Prudential Healthcare Fund 0.02%

BANDHAN SMALL CAP FUND - DIRECT PLAN GROWTH 0%

▼ Exits (2)

THE WEALTH COMPANY FLEXI CAP FUND 1.4%

JioBlackRock Flexi Cap Fund - Direct Plan - Growth Option 0.03%

↑ Increased (11)

Sundaram Long Term Tax Advantage Fund Series IV Direct Plan - Growth +0.05%

Sundaram Long Term Micro Cap Tax Advantage Fund Series III Direct Plan - Growth +0.03%

Sundaram Long Term Micro Cap Tax Advantage Fund Series VI Direct Plan - Growth +0.02%

Sundaram Long Term Micro Cap Tax Advantage Fund Series IV Direct Plan - Growth +0.04%

Sundaram Long Term Tax Advantage Fund Series III Direct Plan - Growth +0.02%

Sundaram Long Term Micro Cap Tax Advantage Fund Series V Direct Plan - Growth +0.03%

NJ Value Fund +0.06%

BANDHAN MULTI CAP FUND - GROWTH - DIRECT PLAN +0.02%

↓ Decreased (2)

Sundaram Small Cap Fund Direct Plan - Growth -0.01%

ICICI Prudential ESG Exclusionary Strategy Fund - Direct Plan - Growth -0.23%

By Category

Which Fund Categories Hold This Stock?

Category	Funds	Avg Weight
Equity	11	1.02%
Value/Contra	3	0.82%
Small Cap	3	0.54%
Multi Cap	1	0.77%

All Holdings

Which 18 Active Funds Hold Natco Pharma Limited?

Filter:

Fund ↕	Category ↕	Weight ↕	Value ↕	Change ↕
Tata India Pharma & Healthcare Fund-Direct Plan-Growth Tata Mutual Fund	Equity	1.51%	₹22.77 Cr	NEW
Sundaram Long Term Tax Advantage Fund Series IV Direct Plan - Growth Sundaram Mutual Fund	Equity	1.44%	₹31.01 L	+0.05%
Sundaram Long Term Micro Cap Tax Advantage Fund Series III Direct Plan - Growth Sundaram Mutual Fund	Equity	1.43%	₹1.07 Cr	+0.03%
Sundaram Long Term Micro Cap Tax Advantage Fund Series VI Direct Plan - Growth Sundaram Mutual Fund	Equity	1.43%	₹51.16 L	+0.02%
Sundaram Long Term Micro Cap Tax Advantage Fund Series IV Direct Plan - Growth Sundaram Mutual Fund	Equity	1.42%	₹50.55 L	+0.04%
Sundaram Long Term Tax Advantage Fund Series III Direct Plan - Growth Sundaram Mutual Fund	Equity	1.39%	₹46.97 L	+0.02%
Sundaram Long Term Micro Cap Tax Advantage Fund Series V Direct Plan - Growth Sundaram Mutual Fund	Equity	1.38%	₹42.53 L	+0.03%
NJ Value Fund NJ Mutual Fund	Value/Contra	1.29%	₹2.53 Cr	+0.06%
Sundaram Small Cap Fund Direct Plan - Growth Sundaram Mutual Fund	Small Cap	1.11%	₹45.65 Cr	-0.01%
ADITYA BIRLA SUN LIFE PHARMA & HEALTHCARE FUND Aditya Birla Sun Life Mutual Fund	Equity	0.92%	₹9.93 Cr	—
BANDHAN MULTI CAP FUND - GROWTH - DIRECT PLAN Bandhan Mutual Fund	Multi Cap	0.77%	₹22.76 Cr	+0.02%
Tata Value Fund -Direct Plan Growth Option Tata Mutual Fund	Value/Contra	0.7%	₹57.93 Cr	+0.02%
Tata Small Cap Fund-Direct Plan-Growth Tata Mutual Fund	Small Cap	0.52%	₹68.57 Cr	+0.17%
JM Value Fund (Direct) - Growth Option JM Financial Mutual Fund	Value/Contra	0.48%	₹3.72 Cr	+0.02%
ICICI Prudential ESG Exclusionary Strategy Fund - Direct Plan - Growth ICICI Prudential Mutual Fund	Equity	0.27%	₹3.41 Cr	-0.23%
JioBlackRock Sector Rotation Fund - Direct Plan - Growth Option JioBlackRock Mutual Fund	Equity	0.06%	₹10.10 L	—
ICICI Prudential Healthcare Fund ICICI Prudential Mutual Fund	Equity	0.02%	₹1.36 Cr	NEW
BANDHAN SMALL CAP FUND - DIRECT PLAN GROWTH Bandhan Mutual Fund	Small Cap	0%	₹74.48 L	NEW

Explore More

← Stock Search Top Stocks by MF Conviction Fund Directory AMC AAUM Rankings Market Cap Categories

Data source: Official AMFI monthly portfolio disclosures. Updated every month. Index funds and ETFs excluded. Disclaimer: This is not investment advice. Consult a SEBI-registered advisor before investing.